No Man

No Man flag

More

Categories

Niraparib

TypeName: Business Offer
Category:
Offer Date:2019/06/10
Country: United States
Summary: Niraparib is an inhibitor of PARP, which was approved by FDA for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. https://www.bocsci.com/niraparib-cas-1038915-60-4-item-408479.html
Description:
OfferId: 4505
Name:Alex Brown
Telphone:
Email:[email protected]

Advertising

dfwHR
Force Fabrication Inc.
Hatch Power
Hibachi Family
iindigo
Kentish Town House Clearance
Kilburn House Clearance
Categories